Copyright Reports & Markets. All rights reserved.

Global Immunity Booster Supplement Market Research Report 2021

Request for Sample of this report
Buy now

1 Immunity Booster Supplement Market Overview

  • 1.1 Product Overview and Scope of Immunity Booster Supplement
  • 1.2 Immunity Booster Supplement Segment by Type
    • 1.2.1 Global Immunity Booster Supplement Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Capsule
    • 1.2.3 Liquid
    • 1.2.4 Pill
    • 1.2.5 Powder
  • 1.3 Immunity Booster Supplement Segment by Application
    • 1.3.1 Immunity Booster Supplement Sales Comparison by Application: (2021-2027)
    • 1.3.2 Offline
    • 1.3.3 Online
  • 1.4 Global Immunity Booster Supplement Market Size Estimates and Forecasts
    • 1.4.1 Global Immunity Booster Supplement Revenue 2016-2027
    • 1.4.2 Global Immunity Booster Supplement Sales 2016-2027
    • 1.4.3 Immunity Booster Supplement Market Size by Region: 2016 Versus 2021 Versus 2027

2 Immunity Booster Supplement Market Competition by Manufacturers

  • 2.1 Global Immunity Booster Supplement Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Immunity Booster Supplement Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Immunity Booster Supplement Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Immunity Booster Supplement Manufacturing Sites, Area Served, Product Type
  • 2.5 Immunity Booster Supplement Market Competitive Situation and Trends
    • 2.5.1 Immunity Booster Supplement Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Immunity Booster Supplement Players Market Share by Revenue
    • 2.5.3 Global Immunity Booster Supplement Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Immunity Booster Supplement Retrospective Market Scenario by Region

  • 3.1 Global Immunity Booster Supplement Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Immunity Booster Supplement Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Immunity Booster Supplement Market Facts & Figures by Country
    • 3.3.1 North America Immunity Booster Supplement Sales by Country
    • 3.3.2 North America Immunity Booster Supplement Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Immunity Booster Supplement Market Facts & Figures by Country
    • 3.4.1 Europe Immunity Booster Supplement Sales by Country
    • 3.4.2 Europe Immunity Booster Supplement Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Immunity Booster Supplement Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Immunity Booster Supplement Sales by Region
    • 3.5.2 Asia Pacific Immunity Booster Supplement Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Immunity Booster Supplement Market Facts & Figures by Country
    • 3.6.1 Latin America Immunity Booster Supplement Sales by Country
    • 3.6.2 Latin America Immunity Booster Supplement Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Immunity Booster Supplement Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Immunity Booster Supplement Sales by Country
    • 3.7.2 Middle East and Africa Immunity Booster Supplement Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Immunity Booster Supplement Historic Market Analysis by Type

  • 4.1 Global Immunity Booster Supplement Sales Market Share by Type (2016-2021)
  • 4.2 Global Immunity Booster Supplement Revenue Market Share by Type (2016-2021)
  • 4.3 Global Immunity Booster Supplement Price by Type (2016-2021)

5 Global Immunity Booster Supplement Historic Market Analysis by Application

  • 5.1 Global Immunity Booster Supplement Sales Market Share by Application (2016-2021)
  • 5.2 Global Immunity Booster Supplement Revenue Market Share by Application (2016-2021)
  • 5.3 Global Immunity Booster Supplement Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Airborne
    • 6.1.1 Airborne Corporation Information
    • 6.1.2 Airborne Description and Business Overview
    • 6.1.3 Airborne Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Airborne Product Portfolio
    • 6.1.5 Airborne Recent Developments/Updates
  • 6.2 Amway Corp.
    • 6.2.1 Amway Corp. Corporation Information
    • 6.2.2 Amway Corp. Description and Business Overview
    • 6.2.3 Amway Corp. Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Amway Corp. Product Portfolio
    • 6.2.5 Amway Corp. Recent Developments/Updates
  • 6.3 Archer-Daniels-Midland Company
    • 6.3.1 Archer-Daniels-Midland Company Corporation Information
    • 6.3.2 Archer-Daniels-Midland Company Description and Business Overview
    • 6.3.3 Archer-Daniels-Midland Company Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Archer-Daniels-Midland Company Product Portfolio
    • 6.3.5 Archer-Daniels-Midland Company Recent Developments/Updates
  • 6.4 ARKOPHARMA Laboratories
    • 6.4.1 ARKOPHARMA Laboratories Corporation Information
    • 6.4.2 ARKOPHARMA Laboratories Description and Business Overview
    • 6.4.3 ARKOPHARMA Laboratories Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 ARKOPHARMA Laboratories Product Portfolio
    • 6.4.5 ARKOPHARMA Laboratories Recent Developments/Updates
  • 6.5 Vitafusion
    • 6.5.1 Vitafusion Corporation Information
    • 6.5.2 Vitafusion Description and Business Overview
    • 6.5.3 Vitafusion Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Vitafusion Product Portfolio
    • 6.5.5 Vitafusion Recent Developments/Updates
  • 6.6 Bayer AG
    • 6.6.1 Bayer AG Corporation Information
    • 6.6.2 Bayer AG Description and Business Overview
    • 6.6.3 Bayer AG Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Bayer AG Product Portfolio
    • 6.6.5 Bayer AG Recent Developments/Updates
  • 6.7 Pfizer
    • 6.6.1 Pfizer Corporation Information
    • 6.6.2 Pfizer Description and Business Overview
    • 6.6.3 Pfizer Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Pfizer Product Portfolio
    • 6.7.5 Pfizer Recent Developments/Updates
  • 6.8 Suntory Holdings Ltd
    • 6.8.1 Suntory Holdings Ltd Corporation Information
    • 6.8.2 Suntory Holdings Ltd Description and Business Overview
    • 6.8.3 Suntory Holdings Ltd Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Suntory Holdings Ltd Product Portfolio
    • 6.8.5 Suntory Holdings Ltd Recent Developments/Updates
  • 6.9 Cyanotech Co.
    • 6.9.1 Cyanotech Co. Corporation Information
    • 6.9.2 Cyanotech Co. Description and Business Overview
    • 6.9.3 Cyanotech Co. Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Cyanotech Co. Product Portfolio
    • 6.9.5 Cyanotech Co. Recent Developments/Updates
  • 6.10 DuPont de Nemours Inc.
    • 6.10.1 DuPont de Nemours Inc. Corporation Information
    • 6.10.2 DuPont de Nemours Inc. Description and Business Overview
    • 6.10.3 DuPont de Nemours Inc. Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 DuPont de Nemours Inc. Product Portfolio
    • 6.10.5 DuPont de Nemours Inc. Recent Developments/Updates
  • 6.11 Pfizer Inc.
    • 6.11.1 Pfizer Inc. Corporation Information
    • 6.11.2 Pfizer Inc. Immunity Booster Supplement Description and Business Overview
    • 6.11.3 Pfizer Inc. Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Pfizer Inc. Product Portfolio
    • 6.11.5 Pfizer Inc. Recent Developments/Updates
  • 6.12 Enterogermina
    • 6.12.1 Enterogermina Corporation Information
    • 6.12.2 Enterogermina Immunity Booster Supplement Description and Business Overview
    • 6.12.3 Enterogermina Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Enterogermina Product Portfolio
    • 6.12.5 Enterogermina Recent Developments/Updates
  • 6.13 Equate
    • 6.13.1 Equate Corporation Information
    • 6.13.2 Equate Immunity Booster Supplement Description and Business Overview
    • 6.13.3 Equate Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Equate Product Portfolio
    • 6.13.5 Equate Recent Developments/Updates
  • 6.14 FANCL Corporation
    • 6.14.1 FANCL Corporation Corporation Information
    • 6.14.2 FANCL Corporation Immunity Booster Supplement Description and Business Overview
    • 6.14.3 FANCL Corporation Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 FANCL Corporation Product Portfolio
    • 6.14.5 FANCL Corporation Recent Developments/Updates
  • 6.15 Glanbia PLC
    • 6.15.1 Glanbia PLC Corporation Information
    • 6.15.2 Glanbia PLC Immunity Booster Supplement Description and Business Overview
    • 6.15.3 Glanbia PLC Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Glanbia PLC Product Portfolio
    • 6.15.5 Glanbia PLC Recent Developments/Updates
  • 6.16 GlaxoSmithKline PLC
    • 6.16.1 GlaxoSmithKline PLC Corporation Information
    • 6.16.2 GlaxoSmithKline PLC Immunity Booster Supplement Description and Business Overview
    • 6.16.3 GlaxoSmithKline PLC Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 GlaxoSmithKline PLC Product Portfolio
    • 6.16.5 GlaxoSmithKline PLC Recent Developments/Updates
  • 6.17 Immunofree
    • 6.17.1 Immunofree Corporation Information
    • 6.17.2 Immunofree Immunity Booster Supplement Description and Business Overview
    • 6.17.3 Immunofree Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Immunofree Product Portfolio
    • 6.17.5 Immunofree Recent Developments/Updates
  • 6.18 Nature Made
    • 6.18.1 Nature Made Corporation Information
    • 6.18.2 Nature Made Immunity Booster Supplement Description and Business Overview
    • 6.18.3 Nature Made Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Nature Made Product Portfolio
    • 6.18.5 Nature Made Recent Developments/Updates
  • 6.19 Nature’s Bounty
    • 6.19.1 Nature’s Bounty Corporation Information
    • 6.19.2 Nature’s Bounty Immunity Booster Supplement Description and Business Overview
    • 6.19.3 Nature’s Bounty Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Nature’s Bounty Product Portfolio
    • 6.19.5 Nature’s Bounty Recent Developments/Updates
  • 6.20 Sanofi S.A.
    • 6.20.1 Sanofi S.A. Corporation Information
    • 6.20.2 Sanofi S.A. Immunity Booster Supplement Description and Business Overview
    • 6.20.3 Sanofi S.A. Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Sanofi S.A. Product Portfolio
    • 6.20.5 Sanofi S.A. Recent Developments/Updates
  • 6.21 Nutraceutical International Corporation
    • 6.21.1 Nutraceutical International Corporation Corporation Information
    • 6.21.2 Nutraceutical International Corporation Immunity Booster Supplement Description and Business Overview
    • 6.21.3 Nutraceutical International Corporation Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Nutraceutical International Corporation Product Portfolio
    • 6.21.5 Nutraceutical International Corporation Recent Developments/Updates
  • 6.22 Otsuka Holdings Co. Ltd
    • 6.22.1 Otsuka Holdings Co. Ltd Corporation Information
    • 6.22.2 Otsuka Holdings Co. Ltd Immunity Booster Supplement Description and Business Overview
    • 6.22.3 Otsuka Holdings Co. Ltd Immunity Booster Supplement Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Otsuka Holdings Co. Ltd Product Portfolio
    • 6.22.5 Otsuka Holdings Co. Ltd Recent Developments/Updates

7 Immunity Booster Supplement Manufacturing Cost Analysis

  • 7.1 Immunity Booster Supplement Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Immunity Booster Supplement
  • 7.4 Immunity Booster Supplement Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Immunity Booster Supplement Distributors List
  • 8.3 Immunity Booster Supplement Customers

9 Immunity Booster Supplement Market Dynamics

  • 9.1 Immunity Booster Supplement Industry Trends
  • 9.2 Immunity Booster Supplement Growth Drivers
  • 9.3 Immunity Booster Supplement Market Challenges
  • 9.4 Immunity Booster Supplement Market Restraints

10 Global Market Forecast

  • 10.1 Immunity Booster Supplement Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Immunity Booster Supplement by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Immunity Booster Supplement by Type (2022-2027)
  • 10.2 Immunity Booster Supplement Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Immunity Booster Supplement by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Immunity Booster Supplement by Application (2022-2027)
  • 10.3 Immunity Booster Supplement Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Immunity Booster Supplement by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Immunity Booster Supplement by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Capsule
    Liquid
    Pill
    Powder

    Segment by Application
    Offline
    Online

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Airborne
    Amway Corp.
    Archer-Daniels-Midland Company
    ARKOPHARMA Laboratories
    Vitafusion
    Bayer AG
    Pfizer
    Suntory Holdings Ltd
    Cyanotech Co.
    DuPont de Nemours Inc.
    Pfizer Inc.
    Enterogermina
    Equate
    FANCL Corporation
    Glanbia PLC
    GlaxoSmithKline PLC
    Immunofree
    Nature Made
    Nature’s Bounty
    Sanofi S.A.
    Nutraceutical International Corporation
    Otsuka Holdings Co. Ltd

    Buy now